Metropolitan Health Networks Inc (MDF) Return on Equity ROE from the third quarter 2012 to third quarter 2011 and annually, average high and low, overall ranking from Sep 30 2012 to Sep 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Metropolitan Health Networks Inc  (MDF)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Metropolitan Health Networks Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Metropolitan Health Networks Inc in the third quarter 2012?
Metropolitan Health Networks Inc achieved a return on average equity (ROE) of 17.29 % in its third quarter 2012, this is above MDF's average return on equity of 0%.
Metropolitan Health Networks Inc shareholder's equity over the 12 months ending in its third quarter 2012 are valued at $116 million

ROE has advanced compared to 15.79% in the second quarter 2012, due to net income growth.

Within the Healthcare Facilities industry Metropolitan Health Networks Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2012 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Equity Change 43.11 % 42.22 % 68.47 % - -
Y / Y Net Income Change 54.47 % -50.57 % -0.6 % - 4.06 %
Net Income (TTM) in Millions 20 17 20 20 27
Return On Equity (TTM) 17.29 % 15.79 % 20.27 % 23.05 % 44.37 %
MDF's Total Ranking # # # # #
Equity (TTM) in Millions 128 118 114 105 90
Seq. Equity Change 8.61 % 3.53 % 9.07 % 16.68 % 7.94 %
Seq. Net Income Change 216.22 % -63 % - - 1.18 %

Back to MDF Management Effectiveness >> MDF's 5 Years Annual ROE >> Compare MDF ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





MDF Annual Return On Equity (Dec 31 2011)
2011



Total Equity in Millions 105 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 23 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 21.71 % - - - -

Back to MDF Management Effectiveness >> MDF's 5 Years Annual ROE >> Compare MDF ROE to its Competitors




Annual Roe Comment
In 2011 ROE improved to 21.71 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDF's' Return on Equity at Yahoo Finance
MDF's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDF's Competitors
Subscribers only: Roe for Metropolitan Health Networks Inc's Suppliers
Subscribers only: Return On Equity for MDF's Customers




Companies with similar Return On Equity at Sep 30 2012, within Healthcare Sector ROE
China Health Industries Holdings Inc   40.48 %
Spectrum Pharmaceuticals Inc   38.86 %
Regeneron Pharmaceuticals Inc   37.89 %
Mettler toledo International Inc   35.49 %
Baxter International Inc   33.84 %
Waters Corporation  33.11 %
Gilead Sciences Inc   31.89 %
Idexx Laboratories Inc  31.40 %
Nature s Sunshine Products inc   28.67 %
Varian Medical Systems Inc   28.25 %
Celgene Corp  28.24 %
Eli Lilly And Company  28.06 %
Bard C R Inc  27.60 %
United Therapeutics Corporation  27.23 %
Abbott Laboratories  26.38 %
Becton Dickinson And Company  26.27 %
3m Company  26.24 %
Option Care Health Inc   25.48 %
Abbvie Inc   24.93 %
Agilent Technologies inc   23.93 %
U S Physical Therapy Inc  23.92 %
Meridian Bioscience Inc   23.74 %
Davita Inc   23.32 %
Labcorp Holdings Inc   22.90 %
Utah Medical Products Inc  22.13 %
Biogen Inc   21.64 %
Intuitive Surgical Inc   21.01 %
Medtronic Plc  20.00 %
Vertex Pharmaceuticals Inc  19.43 %
Allergan plc  19.37 %

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.